Host: |
Rabbit |
Applications: |
WB/IHC/IF/ELISA |
Reactivity: |
Human/Rat/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-NADH-ubiquinone oxidoreductase chain 1 (176-225) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300ELISA 1:40000IF 1:50-200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
MT-ND1 |
Gene ID: |
4535 |
Uniprot ID: |
NU1M_HUMAN |
Immunogen Region: |
176-225 |
Specificity: |
ND1 Polyclonal Antibody detects endogenous levels of ND1 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from human MT-ND1. AA range:176-225 |
Function | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. Essential for the catalytic activity and assembly of complex I. |
Protein Name | Nadh-Ubiquinone Oxidoreductase Chain 1Nadh Dehydrogenase Subunit 1 |
Database Links | Reactome: R-HSA-611105Reactome: R-HSA-6799198 |
Cellular Localisation | Mitochondrion Inner MembraneMulti-Pass Membrane Protein |
Alternative Antibody Names | Anti-Nadh-Ubiquinone Oxidoreductase Chain 1 antibodyAnti-Nadh Dehydrogenase Subunit 1 antibodyAnti-MT-ND1 antibodyAnti-MTND1 antibodyAnti-NADH1 antibodyAnti-ND1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance